Xtant Medical Holdings (XTNT) Net Income Growth (3y) (2013 - 2025)
Xtant Medical Holdings (XTNT) Net Income Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 280.49% |
| 10 | Xtant Medical Holdings | 59.93 Mn | 42.60 Mn | 17.75 Mn | 26.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.53% |
| Sep 30, 2025 | 36.72% |
| Jun 30, 2025 | 59.74% |
| Mar 31, 2025 | 26.54% |
| Dec 31, 2024 | -35.76% |
| Sep 30, 2024 | -40.69% |
| Jun 30, 2024 | -73.99% |
| Mar 31, 2024 | -433.36% |
| Dec 31, 2023 | -106.36% |
| Sep 30, 2023 | 106.36% |
| Jun 30, 2023 | 3.85% |
| Mar 31, 2023 | 5.89% |
| Dec 31, 2022 | -135.74% |
| Sep 30, 2022 | -7.79% |
| Jun 30, 2022 | 4.10% |
| Mar 31, 2022 | 7.53% |
| Dec 31, 2021 | 71.85% |
| Sep 30, 2021 | 16.98% |
| Jun 30, 2021 | 47.28% |
| Mar 31, 2021 | 82.33% |